<code id='BEBD386D59'></code><style id='BEBD386D59'></style>
    • <acronym id='BEBD386D59'></acronym>
      <center id='BEBD386D59'><center id='BEBD386D59'><tfoot id='BEBD386D59'></tfoot></center><abbr id='BEBD386D59'><dir id='BEBD386D59'><tfoot id='BEBD386D59'></tfoot><noframes id='BEBD386D59'>

    • <optgroup id='BEBD386D59'><strike id='BEBD386D59'><sup id='BEBD386D59'></sup></strike><code id='BEBD386D59'></code></optgroup>
        1. <b id='BEBD386D59'><label id='BEBD386D59'><select id='BEBD386D59'><dt id='BEBD386D59'><span id='BEBD386D59'></span></dt></select></label></b><u id='BEBD386D59'></u>
          <i id='BEBD386D59'><strike id='BEBD386D59'><tt id='BEBD386D59'><pre id='BEBD386D59'></pre></tt></strike></i>

          explore

          explore

          author:leisure time    Page View:4
          Cathy McMorris Rodgers -- health policy coverage from STAT
          Rep. Cathy McMorris Rodgers (R-Wash.), chair of the House Energy and Commerce Committee. Anna Moneymaker/Getty Images

          WASHINGTON — House Republicans have drafted drug-shortage legislation that differs significantly from the approach Democrats propose to stem shortages of chemotherapies and other critical medicines that hospitals typically use.

          Republicans on the House Energy and Commerce Committee are focused on what they say are the underlying economic reasons for shortages. Hospitals band together to negotiate drug prices, and makers of generic injectables say those group purchasing organizations can drive prices down so low that they stop making certain drugs or can’t afford to maintain manufacturing facilities, which then leads to manufacturing interruptions.

          advertisement

          Rep. Frank Pallone (D-N.J.), the ranking Democrat on Energy and Commerce, called some of the Republican proposals “handouts” to drug companies and said they don’t fix the problem. Democrats also have been critical of Republicans’ choice to separate the drug shortage policies from a must-pass pandemic-preparedness bill — they’d rather combine the two efforts to increase its chances of success.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          What does generative AI mean for health care? We asked experts
          What does generative AI mean for health care? We asked experts

          MikeReddyforSTATHealthcarecompaniesareracingtoincorporategenerativeAItoolsintotheirproductpipelinesa

          read more
          Medicare Advantage enrollment hits roughly 33.4 million
          Medicare Advantage enrollment hits roughly 33.4 million

          AdobeYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followingtheflowofmoneyinmed

          read more
          Novavax promises a turnaround & Lilly roils the obesity market
          Novavax promises a turnaround & Lilly roils the obesity market

          SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

          read more

          AbbVie CEO Gonzalez to step down after a decade fiercely defending Humira

          AbbvieCEORichardGonzalezwillstepdowninJuly.JacquelynMartin/APAbbVieannouncedTuesdaythatCEORichardGon